Answers are grounded in this paper and cite their sources.
Development of irAEs was associated with survival outcome of nivolumab treatment in patients with advanced or recurrent NSCLC. Further studies are needed to confirm our findings.
No takes yet. Share an insight, caveat, or question.
Haratani et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: